ストックスクリーナーアプリを入手
0.00
100.00%
-14.00
アフターアワーズ：
13.99
13.99
+
前日終値:
$14.00
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$1.00B
収益：
-
当期純損益:
$-106.61M
株価収益率:
0.00
EPS:
-1.4995
ネットキャッシュフロー:
$-87.87M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$25.00
Ventyx Biosciences Inc Stock (VTYX) Company Profile
名前
Ventyx Biosciences Inc
セクター
電話
(760) 407-6511
住所
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Compare VTYX vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
0.00 | 1.00B | 0 | -106.61M | -87.87M | -1.4995 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-05 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-03-12 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-03-12 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2023-11-07 | ダウングレード | Stifel | Buy → Hold |
| 2023-11-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | 再開されました | Credit Suisse | Outperform |
| 2023-03-21 | 開始されました | Wells Fargo | Overweight |
| 2022-12-19 | 開始されました | Goldman | Buy |
| 2022-11-17 | 開始されました | Morgan Stanley | Overweight |
| 2022-09-07 | 開始されました | Stifel | Buy |
| 2022-09-01 | 開始されました | H.C. Wainwright | Buy |
| 2022-05-09 | 開始されました | Credit Suisse | Outperform |
| 2022-03-31 | 開始されました | Canaccord Genuity | Buy |
| 2022-02-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-15 | 開始されました | Jefferies | Buy |
| 2021-11-15 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Ventyx Biosciences Inc (VTYX) 最新ニュース
Ventyx Biosciences Inc (VTYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ventyx Biosciences Inc (VTYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ventyx Biosciences Inc (VTYX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Ventyx Biosciences Inc (VTYX) Institutional Confidence - TradingKey
Ventyx Biosciences Inc (VTYX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Ventyx Biosciences Inc (VTYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Ventyx Biosciences Inc (VTYX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ventyx Biosciences Inc (VTYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Ventyx Biosciences Inc (VTYX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesVTYX - TMX Newsfile
Ventyx Biosciences (VTYX) Price Target Increased by 10.39% to 12.39 - MSN
Ventyx Biosciences stock (US92276F1003): clinical setbacks keep investors on edge - AD HOC NEWS
Affinity Asset Advisors amends 13G/A for Ventyx Bioscience (VTYX) — 0 shares reported - Stock Titan
Ventyx Biosciences stock (US92276F1003): Acquired by Eli Lilly for $1.2B in January - AD HOC NEWS
In the mix post-Ventyx, more NLRP3s to seize? - BioWorld News
Ventyx Biosciences, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
LifeSci Capital downgrades Ventyx Biosciences (VTYX) - MSN
Eli Lilly to acquire Ventyx Biosciences in $1.2 billion deal - MSN
Eli Lilly nears deal for Ventyx Biosciences at $14/shareWSJ - msn.com
Oppenheimer Maintains Ventyx Biosciences (VTYX) Outperform Recommendation - MSN
Ventyx Biosciences stock (US92276F1003): Is its immunology pipeline strong enough to unlock biotech - AD HOC NEWS
Winners Losers: Does Ventyx Biosciences Inc have a sustainable dividend2026 Weekly Recap & Real-Time Market Sentiment Reports - baoquankhu1.vn
Can Ventyx Biosciences Inc benefit from deglobalization2026 Trade Ideas & Step-by-Step Swing Trade Plans - baoquankhu1.vn
VTYX Stock: A Deep Dive into Ventyx Biosciences - Bitget
Insider Sell: How does Ventyx Biosciences Inc correlate with Nasdaq2026 Growth vs Value & Trade Opportunity Analysis - baoquankhu1.vn
Levels Update: What are Ventyx Biosciences Incs earnings expectations2026 Highlights & Low Risk High Reward Ideas - baoquankhu1.vn
Growth Recap: Will Ventyx Biosciences Inc stock hit new highs in YEARProduct Launch & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Can Ventyx Biosciences Inc outperform in the next rally2026 Fundamental Recap & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Ventyx Biosciences completes $1.2 billion acquisition by Eli Lilly, delists from Nasdaq - Investing.com
Ventyx Biosciences stock: Acquired for $14—What it means for you now - AD HOC NEWS
VTYX SEC FilingsVentyx Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Oppenheimer downgrades Ventyx Biosciences (VTYX) - MSN
Will Ventyx Biosciences Inc stock hit new highs in YEAR2026 Stock Rankings & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Aug Decliners: Is Ventyx Biosciences Inc forming a double bottomStop Loss & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Published on: 2026-03-27 07:56:14 - baoquankhu1.vn
Ventyx Biosciences stock faces uncertainty after pipeline setback and strategic review - AD HOC NEWS
If You Invested $1,000 in Ventyx Biosciences, Inc. (VTYX) - Stock Titan
Market Fear: How does Ventyx Biosciences Inc score in quality rankings2026 Trading Recap & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Aug PostEarnings: Can Ventyx Biosciences Inc benefit from deglobalizationEarnings Trend Report & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Aug Swings: Is Ventyx Biosciences Inc stock forming a triangle pattern2026 Stock Rankings & Capital Efficient Trading Techniques - baoquankhu1.vn
[15-12G] Ventyx Biosciences, Inc. SEC Filing - Stock Titan
Growth Recap: Does Ventyx Biosciences Inc stock reflect fundamentalsWeekly Trade Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Breakout Move: Is Ventyx Biosciences Inc stock overvalued or fairly priced2026 Update & Consistent Profit Trading Strategies - baoquankhu1.vn
[EFFECT] Ventyx Biosciences, Inc. SEC Filing - Stock Titan
Ventyx Biosciences Stock: Retail Buzz Spikes After Phase 2 Win In Obesity And Heart Risk Study - MSN
Ventyx Biosciences (NASDAQ:VTYX) Upgraded to Hold at Wall Street Zen - MarketBeat
Why Ventyx Biosciences Inc. stock is rated strong buyJuly 2025 Weekly Recap & High Return Trade Guides - Naître et grandir
Lilly nearing $1 billion deal with biotech Ventyx, WSJ says - MSN
Assessing Ventyx Biosciences (VTYX) Valuation After A Sharp 90 Day Share Price Rebound - simplywall.st
Eli Lilly buys Ventyx (VTYX) in all-cash $14 per share merger - Stock Titan
Ventyx Biosciences, Inc.(NasdaqGS:VTYX) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Ventyx Biosciences Inc (VTYX) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
1.44%
大文字化:
|
ボリューム (24 時間):